☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Vaccine
What Are The Signs Of A Vaccine Injury?
February 28, 2023
Bavarian Nordic Plans to Initiate P-III Trial of Respiratory Syncytial Virus Candidate MVA-BN
December 6, 2021
AstraZeneca's COVID-19 Vaccine Demonstrates 92% Efficacy Against Delta (Indian) Variant
June 15, 2021
Moderna's mRNA-1273 Meets its Primary Endpoint in P-II/III TeenCOVE Study to Prevent COVID 19 in Adolescents
May 26, 2021
Medicago and GSK Report Results of Plant-Derived Vaccine in a P-II Study for COVID-19
May 18, 2021
Sanofi and GSK Report Results of its COVID-19 Vaccine in a P-II Study Across All Adult Age Groups
May 17, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.